Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anh Do

Showing results (211-220 of 379) with videos related to

Pageof 38
Sort By:
Cancer|February 19, 2009
Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontinJami Mandelin, Emme C K Lin, Dana D Hu, et al.
International Journal of Molecular Sciences|March 29, 2023
DNA Methylation of Window of Implantation Genes in Cervical Secretions Predicts Ongoing Pregnancy in Infertility TreatmentQuang Anh Do, Po-Hsuan Su, Chien-Wen Chen, et al.
Clinical & Experimental Metastasis|March 8, 2008
Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapyToshio Kuwai, Toru Nakamura, Takamitsu Sasaki, et al.
Blood|November 26, 2002
Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significanceTaghi Manshouri, Kim-anh Do, Xuemei Wang, et al.
The Prostate|October 3, 2006
Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor on tumor-associated endothelial cellsJ Erik Busby, Sun-Jin Kim, Sertac Yazici, et al.
Cancer|June 24, 2006
Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinomaNizar Tannir, Eric Jonasch, Lance C Pagliaro, et al.
Clinical Epigenetics|May 2, 2018
Metabolic and inflammatory biomarkers are associated with epigenetic aging acceleration estimates in the GOLDN studyMarguerite R Irvin, Stella Aslibekyan, Anh Do, et al.
Blood|October 5, 2014
Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)Constantine S Tam, Susan O'Brien, William Plunkett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2012
Gene expression, molecular class changes, and pathway analysis after neoadjuvant systemic therapy for breast cancerAna M Gonzalez-Angulo, Takayuki Iwamoto, Shuying Liu, et al.
Cancer|May 16, 2006
Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy aloneApostolia M Tsimberidou, Daniel Catovsky, Ellen Schlette, et al.
Pageof 38

Showing results (211-220 of 379) with videos related to

Sort By:
Pageof 38
Cancer|February 19, 2009
Extracellular and intracellular mechanisms that mediate the metastatic activity of exogenous osteopontinJami Mandelin, Emme C K Lin, Dana D Hu, et al.
International Journal of Molecular Sciences|March 29, 2023
DNA Methylation of Window of Implantation Genes in Cervical Secretions Predicts Ongoing Pregnancy in Infertility TreatmentQuang Anh Do, Po-Hsuan Su, Chien-Wen Chen, et al.
Clinical & Experimental Metastasis|March 8, 2008
Targeting the EGFR, VEGFR, and PDGFR on colon cancer cells and stromal cells is required for therapyToshio Kuwai, Toru Nakamura, Takamitsu Sasaki, et al.
Blood|November 26, 2002
Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significanceTaghi Manshouri, Kim-anh Do, Xuemei Wang, et al.
The Prostate|October 3, 2006
Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor on tumor-associated endothelial cellsJ Erik Busby, Sun-Jin Kim, Sertac Yazici, et al.
Cancer|June 24, 2006
Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinomaNizar Tannir, Eric Jonasch, Lance C Pagliaro, et al.
Clinical Epigenetics|May 2, 2018
Metabolic and inflammatory biomarkers are associated with epigenetic aging acceleration estimates in the GOLDN studyMarguerite R Irvin, Stella Aslibekyan, Anh Do, et al.
Blood|October 5, 2014
Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)Constantine S Tam, Susan O'Brien, William Plunkett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2012
Gene expression, molecular class changes, and pathway analysis after neoadjuvant systemic therapy for breast cancerAna M Gonzalez-Angulo, Takayuki Iwamoto, Shuying Liu, et al.
Cancer|May 16, 2006
Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy aloneApostolia M Tsimberidou, Daniel Catovsky, Ellen Schlette, et al.
Pageof 38